TaxTMI Login
Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
of 
of 
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of of 
All News
of of All News
Note
Bookmark
Share
Don't have an account? Register Here
of <h1>Pharma Giant Boosts API Production with 46% EBITDA Growth, Expands Manufacturing Capabilities Nationwide</h1> Pharmaceutical company expands operations in microcrystalline cellulose and active pharmaceutical ingredients. Achieved significant financial growth with 46.21% EBITDA increase and 25.42% revenue surge in fiscal year 2025. Received environmental approval for new facility in Andhra Pradesh, aiming to strengthen API pipeline and global market presence. Company maintains leadership in MCC manufacturing, with five production units and high-quality standards, targeting 25% growth through fiscal year 2028.
TaxTMI 
TaxTMI 
